Clinical Trials Browser

Completed × Multiple Myeloma × 10-propargyl-10-deazaaminopterin × Clear all

Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT01114282 2016-07-06

Phase I Bortezomib (VELCADE) in Combo With Pralatrexate in Relapsed/Refractory MM

Phase 1 Completed

11 enrolled

Plasma cell

Multiple Myeloma

Clinical Trials

PDX+Romi

Phase I Bortezomib (VELCADE) in Combo With Pralatrexate in Relapsed/Refractory MM